Table 3.
Study | Study design | Treatment | Participants (n) | Women (%) | Aneurysm size range (mm) | Periprocedural stroke |
---|---|---|---|---|---|---|
Wiebers et al. 24 a | Observational | No treatment, EVT, MST | 4060 | 76 | 2–≥25 mm (range) | MST: 286/1917 |
EVT: 36/451 | ||||||
Brilstra et al. 35 | Observational | EVT, MST | 51 | 75 | 0–>25 (range) | MST: 11/32 |
EVT: 3/19 | ||||||
Gallas et al. 36 | Observational | EVT | 302 | 63 | NA b | EVT: 36/302 |
Guglielmi detachable coils | ||||||
Gentric et al. 37 | Observational | EVT | 107 | 69 | NA c | EVT: 6/107 |
Stent assisted coilling | ||||||
Hetts et al. 38 | Observational | EVT | 361 | 77 | 4–20 (range) | EVT: 22/361 |
Stent assisted coil, simple coil | ||||||
Poncyljusz et al. 39 | Observational | EVT | 78 | 73 | NA | – |
LVIS and LVIS Jr. stents | ||||||
Darsaut et al. 27 | RCT | EVT, MST | 136 | 69 | 3–25 (range) | MST: 3/65 |
EVT: 7/69 | ||||||
Pumar et al. 40 | Observational | EVT | 104 | 75 | <10 mm | EVT: 7/104 |
SILK flow diverter | ||||||
Hanel et al. 41 | Observational | EVT | 141 | 88 | ≤12 mm d | – |
Pipeline embolisation device for wide necked aneurysms |
EVT: endovascular treatment; MST: microsurgical treatment; NA: not available; RCT: randomised controlled trial.
A small proportion of patients had an associated condition, such as arteriovenous malformation (2.0%) or polycystic kidney disease (1.6%).
Aneurysms <10 mm represented 77% of the participants.
Aneurysms <6 mm represented 52% of the participants.
Aneurysms 7 to 12 mm represented 16% of the participants.